The 12 closest competitors and alternatives to Mammoth Biosciences among biotechnology companies — ranked by similarity to what Mammoth Biosciences actually does, not by market-cap band.
Subscribe to see Mammoth Biosciences’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Mammoth Biosciences is a biotechnology company based in Brisbane, California developing diagnostic tests using CRISPR-Cas12a and CRISPR-based therapies using its proprietary ultra-small CRISPR systems. Several CRISPR-Cas systems identified through the company's metagenomics-based protein discovery platform, including members of the Casφ and Cas14 families of CRISPR-associated enzymes, have demonstrated potential for therapeutic genome editing in in vivo settings.
Mammoth Biosciences is a biotechnology company headquartered in United States, founded in 2017. It has raised at least $65.6M across the 3 funding rounds on record. Its most recent funding round raised $45M in January 2020. Xcout recorded 5 job postings from Mammoth Biosciences in the last 90 days.
At least $65.6M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $45M | 1 named | |
| SEC Form D filing | $7.4M | — | |
| SEC Form D filing | $13.2M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 5 job postings from Mammoth Biosciences in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Mammoth Biosciences's hiring signals →
Ranked by semantic similarity — how close each company is to Mammoth Biosciences by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology, Consumer Genetics, Healthcare
23andMe, Inc. is a leading consumer genetics and research company that helps people access, understand, and benefit from their genetic information. It offers DNA testing services for ancestry and health, and utilizes its crowdsourced genetic research platform for drug discovery programs across various disease areas.
Biotech
Metagenomi, Inc. operates as a biotechnology company focused on gene editing, committed to developing therapeutic solutions for patients. The company utilizes a distinctive genome editing toolkit, sourced from metagenomics, for its development efforts within the United States. This advanced toolkit comprises programmable nucleases, base editors, and sophisticated RNA and DNA-mediated integration systems, notably prime editing and CRISPR-associated transposases. Metagenomi has established several key collaborations: a strategic alliance with ModernaTX, Inc. to explore new genome editing systems for in vivo human therapeutic applications; a development and licensing agreement with Affini-T Therapeutics, Inc. to create and commercialize gene-edited T-cell receptor therapies for human cancer; and a partnership with Ionis Pharmaceuticals, Inc. to research, develop, and market investigational medicines leveraging genome editing technologies. Founded in 2016, the company is based in Emeryville, California.
Similar biotechnology company
Excision BioTherapeutics Inc. is a San Francisco-based clinical-stage biotechnology company focused on developing advanced gene editing therapeutics to treat infectious diseases.
Similar biotechnology company
Colossal Biosciences is a biotechnology and genetic science company headquartered in Dallas, Texas, specializing in de-extinction initiatives and advanced genomics research.
Similar biotechnology company
BreezeBio is a biotechnology company headquartered in the South San Francisco area of California that develops precision genetic medicines.
Life Science
Synthorx, Inc., founded in 2014, is a biotechnology company headquartered in La Jolla, California, that engineered expanded genetic alphabet technologies to discover and develop novel protein therapeutics.
Molecular Diagnostics
Molecular Stethoscope, Inc. develops clinical-grade diagnostic products and services, establishing corporate headquarters and research and development laboratories in South San Francisco.
Similar biotechnology company
Sift Biosciences is a privately held biotechnology company founded in 2024 and headquartered in San Carlos, California. The company is focused on harnessing pre-existing hidden immunity.
Similar biotechnology company
SNIPR Biome is a clinical-stage life sciences company headquartered in Copenhagen, Denmark, pioneering precision medicines and CRISPR-guided technologies for difficult-to-treat conditions.
Biotech
Tessera Therapeutics is a biotechnology company developing programmable genetic medicines using its Gene Writing technology, which is based on mobile genetic elements to insert, replace, or modify DNA in cells. It aims to develop treatments for genetic diseases and other serious conditions, serving patients who need durable genetic therapies.
Biotech
Encoded Therapeutics is a biotechnology company headquartered in South San Francisco, California, dedicated to developing next-generation genetic medicines designed to address the root causes of genetic diseases.
Life Sciences
Acrigen Biosciences, Inc. is a biotechnology company headquartered in California, United States. The firm is developing precision gene editing systems and delivery technologies to control CRISPR applications and provide advanced genetic medicines. Its research is conducted in collaboration with academic groups such as UCSF.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Mammoth Biosciencesand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →